At this stage, USP15 in melanoma appears to be involved in the anti-tumor immune response and its targeting could be a useful strategy to inhibit growth by inducing apoptosis of tumor cells by activating anti-tumor immunity and/or by boosting the efficacy of existing immunotherapy. This evidence concerns the gene USP15 and neoplasm.